ArticleJournal of comparative effectiveness research2024
COVID-19 clinical trials: who is likely to participate and why?
Kimberly A Fisher, Mara M Epstein, Ngoc Nguyen, Hassan Fouayzi, Sybil Crawford, Benjamin P Linas, Kathleen M Mazor
Erratum issuedAbstract read
In one paragraphArticle in Journal of comparative effectiveness research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
7 authors.
Kimberly A FisherDivision of Health Systems Science, Department of Medicine, UMass Chan Medical School, Worcester, MA 01655, USA.ORCID 0000-0003-1802-3457 Mara M EpsteinDivision of Health Systems Science, Department of Medicine, UMass Chan Medical School, Worcester, MA 01655, USA.
Ngoc NguyenDivision of Health Systems Science, Department of Medicine, UMass Chan Medical School, Worcester, MA 01655, USA.
Hassan FouayziDivision of Health Systems Science, Department of Medicine, UMass Chan Medical School, Worcester, MA 01655, USA.
Sybil CrawfordTan Chingfen Graduate School of Nursing, UMass Chan Medical School, Worcester, MA 01655, USA.
Benjamin P LinasSection of Infectious Diseases, Department of Medicine, Boston Medical Center, Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, & Boston University School of Public Health, Boston, MA 02118, USA.
Kathleen M MazorDivision of Health Systems Science, Department of Medicine, UMass Chan Medical School, Worcester, MA 01655, USA.
Funding
ACTIV Integration of Host-targeting Therapies for COVID-19 Administrative Coordinating CenterOT2HL156812 · NHLBI · RESEARCH TRIANGLE INSTITUTE · PI NOLEN, TRACY L, THOMAS, SONIA M · 2020 to 2024
$1270.7MNHLBI Maternal Morbidity and Mortality (3M) Administrative Coordinating CenterOT2HL158287 · NHLBI · WESTAT, INC. · PI Chanza Baytop · 2020 to 2026
$433.8MNHLBI NIH HHS OT2 HL156812NHLBI NIH HHS OT2 HL158287
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Clinical Trials as TopicCOVID-19AdultAgedFemaleHumansMaleMassachusettsMiddle AgedPatient ParticipationSARS-CoV-2Surveys and QuestionnairesTrustYoung AdultCOVID-19research participationtrust
Identifiers
PMID39045844
PMCPMC11287768
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390